Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 383 of 6351
-
Exercise as a cancer ally: could a bike ride supercharge immunotherapy?
Disease control Not yet recruitingRecent advances combining chemotherapy and immunotherapy before surgery have significantly improved outcomes for patients with resectable non-small cell lung cancer (NSCLC). However, a substantial proportion of patients still do not respond optimally to these treatments. Research…
Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New drug aims to reduce bulging eyes in thyroid disease
Disease control Recruiting nowThis is a multicenter, randomized, open-label, active-controlled Phase IV clinical trial in participants with active thyroid eye disease (TED). Approximately 92 eligible participants will be randomized to the teprotumumab N01 group and the intravenous glucocorticoid (IVGC) group …
Phase 4 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New drug cocktail takes on rare skin cancer
Disease control Not yet recruitingVG712 (A-dmDT390-bisFv(UCHT1) fusion protein) is a recombinant anti-CD3 immunotoxin that selectively depletes CD3-positive T cells through irreversible inhibition of protein synthesis. This Phase II study (CurbMF-001) evaluates the safety and efficacy of VG712 compared with mogam…
Phase 2 • Sponsor: Virogen Biotechnology Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a new drug help keep myasthenia gravis symptoms at bay?
Disease control Recruiting nowThe primary purpose of this study is to evaluate the efficacy of ublituximab in adult participants with MG responding to treatment with efgartigimod.
Phase 2 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New pill targets rosacea inflammation at its source
Disease control Recruiting nowThis Phase 2 study aims to evaluate whether Bruton's tyrosine kinase (BTK) inhibition with remibrutinib can produce a clinically meaningful reduction in inflammatory lesions in adults with moderate-to-severe papulopustular rosacea, while also assessing safety and tolerability of …
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug targets two cancer proteins in advanced tumors
Disease control Recruiting nowThis is a multicenter, open-label, multiple-dose, FIH Phase 1/2a trial. The Phase 1 portion uses Bayesian optimal interval (BOIN) design to escalate and determine the MTD and/or RP2D with potential backfill cohorts. The Phase 2a portion consists of dose optimization followed by c…
Phase 1/2 • Sponsor: VelaVigo Bio Inc • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Targeting the immune system: a new antibody may free Graves' patients from daily drugs
Disease control Recruiting nowIn this study, researchers will learn more about the use of felzartamab in participants with Graves' Disease, also known as GD. GD is an autoimmune disease, which means the body's immune system attacks its own healthy cells. In people with GD, the immune system produces abnormal …
Phase 2 • Sponsor: Biogen • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Needles and light: a new attack on muscle pain?
Symptom relief Recruiting nowThis study aims to evaluate the effectiveness of dry needling and Low-Level Laser Microcurrent Electrical Stimulation (LL MCES) in patients with acute upper trapezius myofascial pain syndrome (MPS) by assessing both biological and clinical outcomes. Specifically, it investigates …
Sponsor: Udayana University • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Could skipping the breathing tube make heart transplants safer?
Disease control Recruiting nowThis prospective, multicenter, randomized controlled trial aims to evaluate whether non-intubated spontaneous ventilation anesthesia (NISVA) supported by a supraglottic airway can reduce cardiopulmonary complications and promote postoperative recovery in adults undergoing isolate…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can one injection beat back pain? a trial aims to find out
Disease control Recruiting nowThis study aims to analyze the efficacy and safety of different kinds of steroid injections for back pain, comparing different steroids, dosages, locations (epidural, facet joints, nerve blocks), and also the difference between injections with steroids and local anesthetics, to o…
Phase 4 • Sponsor: Igor Wilderman. MD • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New drug combo shows promise for tough lung cancer
Disease control Not yet recruitingThis is a multicenter, open-label, randomized controlled phase II/III study evaluating the efficacy and safety of QL1706 in combination with anlotinib as later-line treatment in patients with advanced lung cancer.
Phase 2/3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for tough lymphoma: TR115 faces off against standard care
Disease control Not yet recruitingThis is a randomized, open-label, multicenter Phase III study evaluating the efficacy and safety of TR115, an EZH2 inhibitor, versus investigator's choice (chidamide, golidocitinib, mitoxantrone liposome, or gemcitabine) in patients with relapsed and/or refractory peripheral T/NK…
Phase 3 • Sponsor: Tarapeutics Science Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Handheld breath test could spot lung disease early
Diagnosis Not yet recruitingThis is a prospective, multicenter, observational cohort study enrolling approximately 4,000 subjects across about 50 centers, including patients with COPD (confirmed and suspected), asthma (confirmed and suspected), bronchiectasis, interstitial lung disease (ILD), upper airway o…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
New migraine prevention pill EVO756 enters Mid-Stage trial
Prevention Recruiting nowThis study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.
Phase 2 • Sponsor: Evommune, Inc. • Aim: Prevention
Last updated Sep 05, 2026 00:00 UTC
-
Could a muscle relaxant speed up recovery after pelvic surgery?
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate whether adding tizanidine to the standard postoperative pain regimen improves recovery after pelvic reconstructive surgery in adult women. The main questions it aims to answer are: Does postoperative tizanidine improve patient-repor…
Phase 2 • Sponsor: Hartford Hospital • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Artificial intelligence may forecast pneumonia after heart surgery
Knowledge-focused Recruiting nowThis multicenter, prospective, observational study aims to address two primary objectives. The first objective is to demonstrate that hospital-acquired pneumonia (nosocomial pneumonia) following cardiac surgery can be predicted using artificial intelligence (AI), and to develop …
Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC
-
Can a new pill help the immune system fight cancer?
Disease control Recruiting nowThis is a study to evaluate the safety and potential anti-tumor activity of an investigational drug called ARV-6723, in participants with advanced solid tumors. This is an open-label study which means that participants and study staff will know that all participants will receive…
Phase 1/2 • Sponsor: Arvinas Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Lullaby or Mother's voice: a new weapon against newborn pain?
Symptom relief Not yet recruitingDuring the adaptation process to the extrauterine environment, healthy newborns face procedures such as hepatitis B vaccination, vitamin K injection, blood sugar monitoring, bilirubin or metabolic disease screening. Heel prick blood sampling, performed for diagnostic purposes, is…
Sponsor: Bilecik Seyh Edebali Universitesi • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Could a smartphone app be the key to better diabetes control?
Disease control Recruiting nowThe purpose of the study is to see if using a diabetes app along with nutrition counseling from a registered dietitian nutritionist can help improve blood sugars and cholesterol levels, quality of life, physical activity, and food and beverage choices.
Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can a Two-Dose drug delay type 1 diabetes as well as a 14-Day treatment?
Disease control Recruiting nowThis is a 2-arm, multi-center, open label study to learn if ATG works the same or better than teplizumab in delaying or preventing Stage 3 Type 1 diabetes. Participants will be administered either 2 infusions of ATG or 14 infusions of teplizumab and will then be followed for at l…
Phase 2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Sep 10, 2026 03:00 UTC